A pharmaceutical composition comprising an anti-CDH6 antibody or its ADC

TW202629596APending Publication Date: 2026-07-16SIMCERE ZAIMING PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
SIMCERE ZAIMING PHARMACEUTICAL CO LTD
Filing Date
2025-10-14
Publication Date
2026-07-16

Smart Images

  • Figure TWG2TA001068772_001
    Figure TWG2TA001068772_001
  • Figure TWG2TA001068772_002
    Figure TWG2TA001068772_002
  • Figure TWG2TA001068772_003
    Figure TWG2TA001068772_003
Patent Text Reader

Abstract

This invention relates to a pharmaceutical composition comprising an anti-CDH6 antibody or its ADC (antibody-drug conjugate). The pharmaceutical composition comprises an anti-CDH6 antibody or its ADC, a buffer, a protein stabilizer, and / or a surfactant. The CDH6 naked antibody formulation of this invention exhibits good long-term stability, and the CDH6 ADC lyophilized formulation achieves stable storage at high concentrations and effectively prevents aggregation and degradation after reconstitution.
Need to check novelty before this filing date? Find Prior Art